Latikafusp represents a unique treatment strategy for managing certain tumors, particularly cases involving fusion ALK proteins. This compound functions as an repressor of truncated anaplastic lymphoma kinase proteins, demonstrating potential in preclinical trials and initial human studies. Its mechanism of function offers a precise way to block re